These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6617867)

  • 1. Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin.
    Ichinose A; Tamaki T; Aoki N
    FEBS Lett; 1983 Mar; 153(2):369-71. PubMed ID: 6617867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.
    Tamaki T; Aoki N
    J Biol Chem; 1982 Dec; 257(24):14767-72. PubMed ID: 6129243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
    Kimura S; Aoki N
    J Biol Chem; 1986 Nov; 261(33):15591-5. PubMed ID: 2877981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor.
    Tamaki T; Aoki N
    Biochim Biophys Acta; 1981 Oct; 661(2):280-6. PubMed ID: 7295739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible cross-linking of alpha 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor.
    Ichinose A; Aoki N
    Biochim Biophys Acta; 1982 Sep; 706(2):158-64. PubMed ID: 6127110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase.
    Lee KN; Lee CS; Tae WC; Jackson KW; Christiansen VJ; McKee PA
    J Biol Chem; 2000 Dec; 275(48):37382-9. PubMed ID: 10958788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
    J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why alpha-antiplasmin must be converted to a derivative form for optimal function.
    Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
    J Thromb Haemost; 2007 Oct; 5(10):2095-104. PubMed ID: 17883704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII.
    Kluft C; Los P; Jie AF
    Thromb Res; 1984 Feb; 33(4):419-25. PubMed ID: 6710441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin.
    Achyuthan KE; Mary A; Greenberg CS
    J Biol Chem; 1988 Oct; 263(28):14296-301. PubMed ID: 2902081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor.
    Kimura S; Tamaki T; Aoki N
    Blood; 1985 Jul; 66(1):157-60. PubMed ID: 3159442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen).
    Greenberg CS; Enghild JJ; Mary A; Dobson JV; Achyuthan KE
    Biochem J; 1988 Dec; 256(3):1013-9. PubMed ID: 3066350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.
    Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
    Blood; 2004 May; 103(10):3783-8. PubMed ID: 14751930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.